Ayrshire Capital Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,932
Closed -$1.04M 54
2026
Q1
$1.04M Sell
4,932
-132
-3% -$33.2K 0.54% 35
2025
Q4
$1.44M Sell
5,064
-13,878
-73% -$4.34M 0.66% 33
2025
Q3
$5.85M Sell
18,942
-4,619
-20% -$1.45M 2.71% 21
2025
Q2
$7.4M Buy
23,561
+27
+0.1% +$7.79K 3.55% 11
2025
Q1
$6.18M Buy
23,534
+546
+2% +$148K 2.99% 18
2024
Q4
$6M Buy
22,988
+5,911
+35% +$1.49M 2.93% 16
2024
Q3
$3.97M Buy
+17,077
New +$3.51M 1.89% 29

Other funds holding PODD

Ayrshire Capital Management's PODD Position: Q2 2026 in Review

Ayrshire Capital Management sold out of Insulet (PODD) in Q2 2026, closing a stake of 4,932 shares — an estimated $1.04M sold.

Ayrshire Capital Management first reported a position in PODD in Q3 2024 and held it in 7 quarters. The position peaked at $7.4M in Q2 2025. 720 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Ayrshire Capital Management reported no remaining Insulet position as of Q2 2026 after selling out during the quarter.
  • Ayrshire Capital Management sold 4,932 Insulet shares in Q2 2026, an estimated $1.04M.
  • Ayrshire Capital Management first reported a position in Insulet in Q3 2024 and held it in 7 quarters.
  • Ayrshire Capital Management's Insulet position peaked at $7.4M in Q2 2025.
  • 720 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Ayrshire Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.